Sangamo Therapeutics, Inc.
NASDAQ:SGMO
2.71 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 176.232 | 111.299 | 110.701 | 118.192 | 102.428 | 84.452 | 36.567 | 19.389 | 39.539 | 45.87 | 24.133 | 21.655 | 10.319 | 20.805 | 22.187 | 16.186 | 9.098 | 7.885 | 2.484 | 1.315 | 2.579 | 4.343 | 4.885 | 3.433 | 2.2 | 2.038 | 1.152 | 0.632 |
| Cost of Revenue
| 22.192 | 12.108 | 9.439 | 180.647 | 145.922 | 114.866 | 65.728 | 65.618 | 67.128 | 56.744 | 36.979 | 31.709 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.232 | -0.7 | 0 | 0 | 0 |
| Gross Profit
| 154.04 | 99.191 | 101.262 | -62.455 | -43.494 | -30.414 | -29.161 | -46.229 | -27.589 | -10.874 | -12.846 | -10.054 | 10.319 | 20.805 | 22.187 | 16.186 | 9.098 | 7.885 | 2.484 | 1.315 | 2.579 | 4.343 | 4.885 | 8.665 | 2.9 | 2.038 | 1.152 | 0.632 |
| Gross Profit Ratio
| 0.874 | 0.891 | 0.915 | -0.528 | -0.425 | -0.36 | -0.797 | -2.384 | -0.698 | -0.237 | -0.532 | -0.464 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2.524 | 1.318 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 230.457 | 249.898 | 230.819 | 180.647 | 145.922 | 114.866 | 65.728 | 65.618 | 67.198 | 56.744 | 36.979 | 31.709 | 32.098 | 33.154 | 28.984 | 31.229 | 25.559 | 21.527 | 11.419 | 11.046 | 10.187 | 13.363 | 15.514 | 11.347 | 4.3 | 4.259 | 1.7 | 0.628 |
| General & Administrative Expenses
| 61.167 | 62.682 | 63.219 | 67.097 | 61.686 | 46.736 | 27.2 | 26.33 | 19.197 | 15.677 | 13.8 | 12.144 | 14.042 | 12.586 | 12.605 | 10.332 | 8.31 | 7.087 | 4.512 | 4.256 | 3.594 | 4.164 | 4.75 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| -23.292 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.663 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 37.875 | 62.682 | 63.219 | 67.097 | 61.686 | 46.736 | 27.2 | 26.33 | 19.197 | 15.677 | 13.8 | 12.144 | 14.042 | 12.586 | 12.605 | 10.332 | 8.31 | 7.087 | 4.512 | 4.919 | 3.594 | 4.164 | 4.75 | 4.569 | 1.8 | 1.237 | 0.797 | 0.322 |
| Other Expenses
| 155.013 | 0 | 0 | 0 | 0 | 0 | 0 | 0.887 | 0.431 | 0.364 | 0.082 | -0.066 | 14.042 | 0 | 0 | 10.332 | 8.31 | 7.087 | 4.813 | 4.919 | 4.161 | 22.174 | 13.062 | 9.801 | 2.5 | 0 | 0 | 0 |
| Operating Expenses
| 268.332 | 312.58 | 294.038 | 247.744 | 207.608 | 161.602 | 92.928 | 91.948 | 86.395 | 72.421 | 50.779 | 43.853 | 46.14 | 45.74 | 41.589 | 41.561 | 33.869 | 28.614 | 16.232 | 15.965 | 14.348 | 35.537 | 20.264 | 21.148 | 6.8 | 5.496 | 2.497 | 0.95 |
| Operating Income
| -114.292 | -201.281 | -183.337 | -129.552 | -105.18 | -77.15 | -56.361 | -72.559 | -46.856 | -26.781 | -26.706 | -22.198 | -35.821 | -24.935 | -19.402 | -25.375 | -24.771 | -20.729 | -13.748 | -14.65 | -11.769 | -31.565 | -28.441 | -12.483 | -3.9 | -3.458 | -1.345 | -0.318 |
| Operating Income Ratio
| -0.649 | -1.808 | -1.656 | -1.096 | -1.027 | -0.914 | -1.541 | -3.742 | -1.185 | -0.584 | -1.107 | -1.025 | -3.471 | -1.199 | -0.874 | -1.568 | -2.723 | -2.629 | -5.535 | -11.141 | -4.563 | -7.268 | -5.822 | -3.636 | -1.773 | -1.697 | -1.168 | -0.503 |
| Total Other Income Expenses Net
| -148.611 | 9.432 | 5.346 | 8.775 | 9.761 | 8.261 | 1.793 | 0.887 | 0.431 | -0.23 | -0.06 | -0.066 | 0.071 | 0.081 | 0.268 | -1.158 | 0.074 | 0.454 | -0.696 | 0.212 | 0.017 | -17.946 | -13.062 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -262.903 | -191.849 | -177.991 | -120.777 | -95.419 | -68.889 | -54.568 | -71.672 | -46.425 | -26.417 | -26.624 | -22.264 | -35.75 | -24.854 | -18.587 | -24.302 | -21.48 | -17.864 | -13.293 | -13.818 | -10.433 | -29.764 | -25.249 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax Ratio
| -1.492 | -1.724 | -1.608 | -1.022 | -0.932 | -0.816 | -1.492 | -3.697 | -1.174 | -0.576 | -1.103 | -1.028 | -3.464 | -1.195 | -0.838 | -1.501 | -2.361 | -2.266 | -5.351 | -10.508 | -4.045 | -6.853 | -5.169 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -5.072 | 0.429 | 0.306 | 0.345 | -19.601 | 8.261 | -1.498 | -0.014 | -5.722 | -0.683 | -0.591 | -0.66 | -0.646 | -0.676 | -0.815 | -1.073 | -1.42 | -2.179 | -0.455 | -0.832 | -1.336 | -1.43 | 9.87 | -3.417 | -0.1 | 3.285 | 1.4 | 0.308 |
| Net Income
| -257.831 | -192.278 | -178.297 | -121.122 | -75.818 | -68.334 | -54.568 | -71.658 | -40.703 | -26.417 | -26.624 | -22.264 | -35.75 | -24.854 | -18.587 | -24.302 | -21.48 | -17.864 | -13.293 | -13.818 | -10.433 | -29.764 | -25.249 | -9.066 | -3.8 | -3.285 | -1.4 | -0.308 |
| Net Income Ratio
| -1.463 | -1.728 | -1.611 | -1.025 | -0.74 | -0.809 | -1.492 | -3.696 | -1.029 | -0.576 | -1.103 | -1.028 | -3.464 | -1.195 | -0.838 | -1.501 | -2.361 | -2.266 | -5.351 | -10.508 | -4.045 | -6.853 | -5.169 | -2.641 | -1.727 | -1.612 | -1.215 | -0.487 |
| EPS
| -1.48 | -1.25 | -1.23 | -0.9 | -0.68 | -0.7 | -0.7 | -1.02 | -0.58 | -0.39 | -0.48 | -0.42 | -0.71 | -0.55 | -0.44 | -0.6 | -0.58 | -0.55 | -0.51 | -0.55 | -0.42 | -1.22 | -1.09 | -0.52 | -0.63 | -0.56 | -0.26 | -0.06 |
| EPS Diluted
| -1.48 | -1.25 | -1.23 | -0.9 | -0.68 | -0.7 | -0.7 | -1.02 | -0.58 | -0.39 | -0.48 | -0.42 | -0.71 | -0.55 | -0.44 | -0.6 | -0.58 | -0.55 | -0.51 | -0.55 | -0.42 | -1.22 | -1.09 | -0.52 | -0.63 | -0.56 | -0.26 | -0.06 |
| EBITDA
| -92.1 | -201.281 | -183.337 | -129.552 | -105.18 | -77.15 | -56.361 | -72.559 | -46.856 | -26.321 | -26.586 | -22.198 | -35.821 | -24.935 | -19.098 | -23.694 | -24.845 | -21.183 | -12.564 | -13.382 | -9.615 | -10.735 | 1.993 | -7.251 | -3.2 | -3.458 | -1.345 | -0.318 |
| EBITDA Ratio
| -0.523 | -1.808 | -1.656 | -1.096 | -1.027 | -0.914 | -1.541 | -3.742 | -1.185 | -0.574 | -1.102 | -1.025 | -3.471 | -1.199 | -0.861 | -1.464 | -2.731 | -2.686 | -5.058 | -10.176 | -3.728 | -2.472 | 0.408 | -2.112 | -1.455 | -1.697 | -1.168 | -0.503 |